Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Return on Capital Employed (2020 - 2025)

Harmony Biosciences Holdings (HRMY) has disclosed Return on Capital Employed for 6 consecutive years, with 0.05% as the latest value for Q4 2025.

  • Quarterly Return on Capital Employed fell 20.0% to 0.05% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.05% through Dec 2025, down 20.0% year-over-year, with the annual reading at 0.05% for FY2025, 21.0% down from the prior year.
  • Return on Capital Employed hit 0.05% in Q4 2025 for Harmony Biosciences Holdings, down from 0.24% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.3% in Q4 2023 to a low of 0.05% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 0.23% across 5 years, with a median of 0.24% in 2024.
  • Biggest five-year swings in Return on Capital Employed: grew 18bps in 2021 and later decreased -20bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.24% in 2021, then dropped by -15bps to 0.21% in 2022, then skyrocketed by 47bps to 0.3% in 2023, then decreased by -21bps to 0.24% in 2024, then tumbled by -81bps to 0.05% in 2025.
  • Business Quant data shows Return on Capital Employed for HRMY at 0.05% in Q4 2025, 0.24% in Q3 2025, and 0.25% in Q2 2025.